Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for and identification of novel agents directed at renal cell carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2001

Mertins S D, Myers T G, Hollingshead M, Dykes D, Bodde E, Tsai P, Jefferis C A, Gupta R, Linehan W M, Alley M, Bates S E

Abstract excerpt

We were interested in identifying novel agents for renal cell carcinoma (RCC) by screening for activities that model renal tumor biology. Searching for relative renal cell sensitivity and leukemia insensitivity among cytotoxicity profiles in the NCI Drug Screen database, we identified 16 potentia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bromodeoxyuridine

Share to Carcinoma, Renal Cell

Share to Drug Design

Share to Inhibitory Concentration 50

Share to Maximum Tolerated Dose

Share to Neoplasm Transplantation

Source

Identifiers

PMID: 11297258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026. Prepared record publication-11297258-2026-08-31.1. Manifest publication-graph-cohort-2026-08-31.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 31 Aug 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Screening for and identification of novel agents directed at renal cell carcinoma.PMID 11297258Read ↗

Developing novel therapeutic strategies for targeting the p53 pathway in renal cell carcinomaSemantic proximity Read ↗

Targeted therapy for patients with renal-cell carcinoma.Semantic proximity Read ↗

Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines.Semantic proximity Read ↗

A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell ProliferationSemantic proximity Read ↗

Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma.Semantic proximity Read ↗

MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines.Semantic proximity Read ↗

Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary types.Semantic proximity Read ↗

Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.Semantic proximity Read ↗

Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.Semantic proximity Read ↗

Heterogeneity and susceptibility to apoptosis of human renal carcinoma cells in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.